K-numberK252173
Device nameF&P OptiNIV Hospital Vented Full Face Mask Compatible with Single-limb Circuits – Size A (ONIV117A); F&P OptiNIV Hospital Vented Full Face Mask Compatible with Single-limb Circuits – Size B (ONIV117B); F&P OptiNIV Hospital Vented Full Face Mask Compatible with Single-limb Circuits – Size C (ONIV117C); F&P OptiNIV ONIV117-F Hospital Vented Full Face Mask with optional Expiratory Filter Compatible with Single-limb Circuits - Size A (ONIV117A-F); F&P OptiNIV ONIV117-F Hospital Vented Full
ApplicantFisher & Paykel Healthcare, Ltd.
Product codeCBK
Device classClass II
Decision dateSep 10, 2025
DecisionSubstantially Equivalent
Regulation868.5895
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The F&P OptiNIV Vented Full Face Mask is an oro-nasal full face mask accessory for delivering non-invasive positive pressure ventilation (NPPV) therapy to spontaneously breathing adult patients (>30 kg) with respiratory insufficiency or respiratory failure. The device consists of a plastic shell with a soft seal and head straps, is single-patient use and non-sterile, and is available in three sizes (A, B, C). It is designed for use in hospital/institutional environments by trained medical practitioners.

Technological characteristics

The subject device operates at 4–30 cmH₂O pressure (compared to predicate's 4–40 cmH₂O), has mask dead space <200 cm³, anti-asphyxiation valve opening/closing pressures of 0.41/0.92 cmH₂O, flow resistance of 0.23 cmH₂O @ 50 L/min and 0.61 cmH₂O @ 100 L/min, uses single-limb breathing circuits with ISO 5356-1 22mm male connectors, is non-sterile, has a maximum mask duration of 14 days and filter duration of 48 hours, and a 3-year shelf life. All characteristics are equivalent or similar to the F&P Visairo NIV Mask predicate (K203449).

Test standards cited

ISO 5356-1:2015 (conical connectors), ISO 17510:2020 (sleep apnea breathing therapy masks and accessories), ISTA 2A:2011 (packaging shock and vibration), IEC 62366-1:2015/AMD 1:2020 (usability engineering), ISO 10993-1:2018 (biocompatibility), ISO 18562-1:2024 and 18562-2:2024 and 18562-3:2024 (breathing gas pathway biocompatibility). Additional testing included shelf-life, venting leak, pressure waveform, humidity delivery, and product leak testing.

Substantial equivalence argument

The subject device is substantially equivalent because it shares identical intended use, patient population (spontaneously breathing adults >30 kg), operating environment (hospital/institutional), and prescription-only status with the predicate. All major technological characteristics are equivalent or similar: pressure range, dead space, anti-asphyxiation valve function, breathing circuit type, connector standards, and durability specifications. Performance testing to applicable consensus standards confirms the device performs safely and effectively in the same manner as the predicate, with no new risks or different mechanism of action.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →